Video: Differential Diagnosis of Thrombotic Microangiopathies (TMA)
Differential Diagnosis of Thrombotic Microangiopathies (TMA)
Join Dr Will Thomas, Consultant Haematologist, Cambridge University Hospitals as he discusses 3 patient presentations of Thrombotic Microangiopathies (TMA). This video explores the differential diagnosis process from both the Clinician’s and Clinical Scientist’s perspective to outline the entire differential diagnosis process.
Cablivi is indicated for the treatment of adults and adolescents of 12 years of age and older weighing at least 40 kg experiencing an episode of acquired thrombotic thrombocytopenic purpura (aTTP), in conjunction with plasma exchange and immunosuppression.
Make the connection between acquired thrombotic thrombocytopenic purpura (aTTP) and unexplained anaemia and thrombocytopenia before it is too late.
Date of Preparation: December 2022